- Home
- VISL vs IMRN Comparison
VISL vs IMRN Comparison
Compare VISL & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VISL
- IMRN
- Stock Information
- Founded
- VISL 2002
- IMRN 1994
- Country
- VISL United States
- IMRN Australia
- Employees
- VISL N/A
- IMRN N/A
- Industry
- VISL Telecommunications Equipment
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- VISL Telecommunications
- IMRN Health Care
- Exchange
- VISL Nasdaq
- IMRN Nasdaq
- Market Cap
- VISL 14.9M
- IMRN 15.0M
- IPO Year
- VISL N/A
- IMRN N/A
- Fundamental
- Price
- VISL $6.10
- IMRN $2.05
- Analyst Decision
- VISL
- IMRN Strong Buy
- Analyst Count
- VISL 0
- IMRN 1
- Target Price
- VISL N/A
- IMRN $5.00
- AVG Volume (30 Days)
- VISL 14.0K
- IMRN 6.6K
- Earning Date
- VISL 11-06-2024
- IMRN 10-22-2024
- Dividend Yield
- VISL N/A
- IMRN N/A
- EPS Growth
- VISL N/A
- IMRN N/A
- EPS
- VISL N/A
- IMRN N/A
- Revenue
- VISL $32,551,000.00
- IMRN $3,271,194.00
- Revenue This Year
- VISL $30.41
- IMRN N/A
- Revenue Next Year
- VISL $11.96
- IMRN N/A
- P/E Ratio
- VISL N/A
- IMRN N/A
- Revenue Growth
- VISL 21.75
- IMRN 171.67
- 52 Week Low
- VISL $2.31
- IMRN $1.48
- 52 Week High
- VISL $8.15
- IMRN $5.96
- Technical
- Relative Strength Index (RSI)
- VISL 42.55
- IMRN 29.63
- Support Level
- VISL $5.82
- IMRN $2.66
- Resistance Level
- VISL $6.40
- IMRN $2.87
- Average True Range (ATR)
- VISL 0.35
- IMRN 0.14
- MACD
- VISL -0.03
- IMRN -0.06
- Stochastic Oscillator
- VISL 12.45
- IMRN 1.50
About VISL Vislink Technologies Inc.
Vislink Technologies Inc is a technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the scene of the action to the viewing screen. It provides solutions for the collection of live news, sports, and entertainment events for the broadcast markets. It also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The company provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.